dc.creatorNguyen, Geoffrey C.
dc.creatorSmalley, Walter E.
dc.creatorSwaroop Vege, Santhi
dc.creatorCarrasco Labra, Alonso
dc.date.accessioned2016-01-18T13:44:56Z
dc.date.available2016-01-18T13:44:56Z
dc.date.created2016-01-18T13:44:56Z
dc.date.issued2016
dc.identifierGastroenterology 2016;150:242–246
dc.identifierDOI: 10.1053/j.gastro.2015.11.008
dc.identifierhttps://repositorio.uchile.cl/handle/2250/136561
dc.description.abstractThis article has an accompanying continuing medical education activity on page e17. Learning Objective: Upon completion of this test, successful learners will be able to: (1) learn first-line treatment for the induction of remission in microscopic colitis; (2) identify the expected clinical benefits and adverse effects of induction therapy for microscopic colitis; (3) understand the indications for and dosing of maintenance therapy for microscopic colitis; (4) consider medications that may precipitate microscopic colitis especially in those who are refractory to medical therapy; and (5) become familiar with treatment strategies for microscopic colitis refractory to first-line therapy.
dc.languageen
dc.publisherElsevier
dc.rightshttp://creativecommons.org/licenses/by-nc-nd/3.0/cl/
dc.rightsAtribución-NoComercial-SinDerivadas 3.0 Chile
dc.subjectCollagenous colitis
dc.subjectAzathioprine
dc.titleAmerican Gastroenterological Association Institute Guideline on the Medical Management of Microscopic Colitis
dc.typeArtículo de revista


Este ítem pertenece a la siguiente institución